APAC Depression Treatment Market Analysis


  • Type: Common Disease Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 4994

  • Format: PPT, PDF

APAC Depression Treatment Market Analysis: Segmented by Product Type, Disorder Type, Distribution Channel – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 4994 Categories: ,

Report Description of the APAC Depression Treatment Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Depression Treatment  Market  Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Depression Treatment  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Depression Treatment Market Analysis Executive Summary

Depression and anxiety disorders are the most common psychiatric disorders affecting a huge population across the globe. Depression; is related to a state of emotion that further affects actions, thoughts and sometimes the sleeping pattern of the concerned person. Depression is the most common type of mental disorder affecting nearly 350 million patients of varied scale age groups, whereas, anxiety is a reaction to stress. Extreme level of anxiety result in anxiety disorders which include phobias, obsessive-compulsive disorder, panic disorder, post-traumatic based stress disorder.

Market Size and Key Findings

The APAC Depression Treatment Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

With the growing age, individuals go through a number of stress conditions. Some of which are common to all age groups, while some are old-age specific such as loss in capabilities to function properly. In addition, the elder people experience reduced socioeconomic status with retirement, which worsen the situation as it leads to isolation and loneliness. Thus, the older people are more vulnerable toward mental disorders, such as anxiety and depression. Thus, the rising cases of anxiety and depression in elderly population, across the world, would help the anxiety and depression treatment market growth. The awareness about mental diseases has increased across the world, owing to the increased initiatives taken by private and public healthcare institutions.

Market Restraints

Although technology is booming in every sector possible still there is lack of awareness of mental disorders and treatments in most of the developing nations hinders the growth of the depression screening market.

COVID-19 impact on “APAC Depression Treatment Market”

The pandemic of COVID 19 has not only affected the physical well-being of individuals, but it affected the psychological aspects also. Prolonged physical distance associated with social isolation, collective grief, the virus itself are some of the major side effects of COVID 19 which everyone has to face and it has put a negative impact on the minds of the people. Because of COVID 19, unemployment has also increased many times which not only affects the financial position but also affects emotionally. These are the few reasons which lead to mental disorders and hence depression.

Competitive Landscape

Key Players

The anxiety and depression treatment market has the presence of various key players, such as Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, GlaxoSmithKline plc., and Sanofi.

Products in Pipeline

  • In March 2021, Cipla Limited announced that it has received the approval for its Abbreviated New Drug Application (ANDA) for sumatriptan nasal spray, 20 mg, from the United States Food and Drug Administration (USFDA). It is a generic therapeutic equivalent version of GlaxoSmithKline plc’s Imitrex nasal spray, a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for the acute treatment of migraine, with or without aura, in adults.
  • In December 2020, H. Lundbeck A/S announced the acceptance of its filing for Vyepti (eptinezumab-jjmr) by the European Medicines Agency (EMA) for Marketing Authorization Application (MAA) review. The filing seeks approval to introduce Vyepti to European citizens who live with migraine and are eligible for preventative therapy. Vyepti is designed to prevent calcitonin gene-related peptide (CGRP) from binding to its receptor, thereby preventing migraine attacks.

Notable Recent Deals

Mergers and acquisitions allow pharmaceutical companies to increase their portfolios, expand their reach, and enhance their workflow, in the anxiety and depression treatment market. Also, several key players are involved in mergers and acquisitions to accelerate the pace of drug discovery and development, in order to gain a competitive edge. For instance, in December 2020, Novartis AG announced to enter into an agreement to acquire Cadent Therapeutics. The acquisition will add two new drugs, which include CAD-9303, a NMDAr positive allosteric modulator; and MIJ-821, a NMDAr negative allosteric modulator, which are in clinical trial stage in the former’s portfolio for neurology and psychiatry. Thus, these development strategies will create a diverse portfolio of depression and anxiety drugs in the market, leading to more demand for such drugs.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The impetus for the research stems from the rising prevalence and cost of Major Depressive Disorder (MDD) in the Asia-Pacific. MDD is a collection of symptoms, which vary at an individual level. Recognition of this reality, and applying the appropriate response, would be a great start. The policy recommendations are primarily along the following three themes:

  • Enforcing nationwide standards for MDD educational campaigns so as to improve understanding – driving more conversations through youths and influencers, requiring employers (public and private) to offer the requisite levels of support, and utilizing platforms for scale such as by establishing “Depression Day”.
  • Providing sustainable coverage to shift toward proper MDD diagnosis and treatment – ensuring national planning cycles account for the MDD spectrum, and formalizing the recognition of caregivers and families who are supporting people living with MDD.
  • Deploying new models of care that are a more effective and efficient use of resources – empowering the use of digital tools in the MDD care systems, reorganizing treatment pathways to reflect a patient-centric mindset, and staying at the forefront of novel interventions.

1. Report Description of the APAC Depression Treatment Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Depression Treatment Market Analysis Executive Summary
2.1 APAC Depression Treatment Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Depression Treatment Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increasing Aging Population
3.1.2 Growing awareness about mental diseases and their treatment
3.2 Market Restraints Analysis
3.2.1 Low public awareness of mental disorders and treatments in emerging nations
3.2.2 Cultural stigma preventing the market growth
3.3 Covid-19 Market Impact Analysis
4. APAC Depression Treatment Market Segmentation
4.1 By Product Type:
4.1.1 Drugs
4.1.2 Devices
4.2 By Disorder Type:
4.2.1 Major Depressive Disorder
4.2.2 OCD
4.2.3 Phobia
4.2.4 PTSD
4.2.5 Others
4.3 By Distribution Channel:
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Channels
4.3.4 Direct Channels
5. APAC Depression Treatment Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Depression Market
6.4 Notable recent deals in Depression Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Novartis AG Company overview
Product & Services, Strategies & Financials
7.2 Bristol-Myers Squibb Company overview
Product & Services, Strategies & Financials
7.3 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.4 Johnson & Johnson Company overview
Product & Services, Strategies & Financials
7.5 AbbVie Inc. Company overview
Product & Services, Strategies & Financials
7.6 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.7 Eli Lilly and company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Depression market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Depression Treatment Market Analysis Segmentation

By Product Type:

Based on product type, the drugs category held larger share in the anxiety and depression treatment market in 2020, and it is also expected to retain its position in upcoming years. This is majorly due to the increasing number of product launches, initiatives taken by private and public health institutions to spread awareness about mental diseases, and research projects for mental disorders.

By Disorder Type:

Based on disorder type, the major depressive disorder category is expected to witness the fastest growth during forecast period in the market for anxiety and depression drugs. This can be mainly attributed to the rise in number of major depressive disorder cases, coupled with growth in public awareness on this issue, and surge in frequency of screening by individuals for better mental health.

By Distribution Channel:

Based on distribution channel, the hospital pharmacies category held the largest share in the anxiety and depression drugs market in 2020, and it is expected to maintain the lead in the coming years. The high sales of anxiety and depression treatment products via this channel are mainly due to the increasing patients visits to look for professional help for their degrading mental health.  

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements